WOCKHARDT BIO AG FDA Approval ANDA 070868

ANDA 070868

WOCKHARDT BIO AG

FDA Drug Application

Application #070868

Application Sponsors

ANDA 070868WOCKHARDT BIO AG

Marketing Status

Prescription001

Application Products

001SYRUP;ORAL250MG/5ML0VALPROIC ACIDVALPROIC ACID

FDA Submissions

ORIG1AP1986-07-01
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1987-04-13
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1987-06-15
LABELING; LabelingSUPPL5AP1989-01-11
LABELING; LabelingSUPPL6AP1993-11-24
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1999-05-04
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1999-05-04
LABELING; LabelingSUPPL9AP2002-05-24
LABELING; LabelingSUPPL10AP2003-03-21
LABELING; LabelingSUPPL12AP2004-03-10
LABELING; LabelingSUPPL14AP2006-12-15
LABELING; LabelingSUPPL15AP2010-01-06

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL4Null0
SUPPL7Null0
SUPPL8Null0
SUPPL15Null7

TE Codes

001PrescriptionAA

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 70868
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.